Bupropion as an aid for smoking cessation;Bupropion som hjelpemiddel for røykeavvenning

Tidsskrift for den Norske Laegeforening

Volumn 122, Issue 27, 2002, Pages 2612-2615

  Tonstad, Serena ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; HUMAN; META ANALYSIS; PRACTICE GUIDELINE; RISK ASSESSMENT; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

EID: 0037058398     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dybing E, Sanner T. Nikotinavhengighet - medisinsk-biologiske forhold. Tidsskr Nor Lægeforen 2002; 122: 302-5.
2. Gamberino WC, Gold MS. Neurobiology of tobacco smoking and other addictive disorders. Psychiatr Clinic North Am 1999; 22: 301-12.
3. Balfour DJ, Ridley DL. The effects of nicotine on neural pathways implicated in depression: A factor in nicotine addiction? Pharmacol Biochem. Behav 2000; 66: 79-85.
4. Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C et al. Smoking and mental illness. Pharmacol Biochem Behav 2001; 70: 561-70.
5. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: A follow-up study. Lancet 2001; 357: 1929-32.
6. Tsoh JY, Humfleet GL, Munoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. Am J Psychiatry 2000; 157: 368-74.
7. Hughes JR, Stead LF, Lancaster T. Anxiolytics for smoking cessation (Cochrane review). I: The Cochrane Library, Issue 2, 2002. Oxford: Update Software, 2002.
8. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation (Cochrane review). I: The Cochrane Library, Issue 2, 2002. Oxford: Update Software, 2002.
9. Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso D. A randomized trial of nortriptyline for smoking cessation. Arch Intern Med 1998; 158: 2035-9.
10. Hall SM, Reus VI, Munoz RF, Sees KL, Humfleet G, Hartz DR et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683-90.
11. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER et al. Treating Tobacco Use and Dependence: Clinical Practice Guidelines. Rockville, MD: US Department of Health and Human Services Public Health Service, 2000.
12. Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 2000; 295: 321-7.
13. Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-202.
14. Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 1999; 174: 173-8.
15. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR et al. A controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-91.
16. Tashkin DP, Kanner R, Bailey W, Buist S, Anderson P, Nides MA et al. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomised trial. Lancet 2001; 357: 1571-5.
17. Gonzales DH, Nides MA, Ferry LH, Kustra RP, Jamerson BD, Segall N et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study. Clin Pharmacol Ther 2001; 69: 438-44.
18. Meyers AW, Klesges RC, Winders SE, Ward KD, Peterson BA, Eck LH. Are weight concerns predictive of smoking cessation? A prospective analysis. J Consult Clin Psychol 1997; 65: 448-52.
19. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Ann Intern Med 2001; 135: 423-33.
20. Chengappa KNR, Kambhampati RK, Perkins K, Nigam R, Anderson T, Brar JS et al. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin re-uptake inhibitor antidepressants. J Clin Psychiatry 2001; 62: 503-8.
21. Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res 2001; 3: 397-403.
22. Guidance on the Use of Nicotine Replacement Therapy (NRT) and Bupropion for Smoking Cessation. Technology Appraisal Guidance - No. 39, March 2002. London: National Institute for Clinical Excellence, 2002.
23. Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA et al. The effect of bupropion on nicotine withdrawal. Psychopharmacologia 2000; 148: 33-40.
24. Patten CA, Rummans TA, Croghan IT, Hurt RD, Hays JT. Development of depression during placebo-controlled trials of bupropion for smoking cessation: Case reports. J Clin Psychiatry 1999; 60: 436-41.
25. Bakke HK. Røyking dreper. Tidsskr Nor Lægeforen 2002; 122: 970.